{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:03Z","timestamp":1787020743255,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2016YFC0901500"],"award-info":[{"award-number":["2016YFC0901500"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2017-I2M-3-001"],"award-info":[{"award-number":["2017-I2M-3-001"]}]},{"name":"Capital health research and development special","award":["2020-2-4017"],"award-info":[{"award-number":["2020-2-4017"]}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"crossref","award":["Z201100005520023"],"award-info":[{"award-number":["Z201100005520023"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to clarify the clinical features of and evaluate the treatment efficacy for IgG4-related thyroiditis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fourteen IgG4-related thyroiditis patients and 42 randomly matched IgG4-related disease (IgG4-RD) patients without thyroiditis in a prospective cohort at the Peking Union Medical College Hospital (PUMCH) were enrolled from 2011 to 2019. Patient demographics, clinical characteristics, laboratory parameters and treatment efficacy were analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of IgG4-related thyroiditis in our cohort was 2.0%. The average patient age was 42.8\u2009\u00b1\u200914.9\u00a0years, and the male: female ratio was 1:1. Goiter (14, 100.0%), hard thyroid (14, 100.0%) and neck compression (5, 35.7%) were the most prevalent onset symptoms observed. IgG4-related thyroiditis was characterized by asymmetric diffuse thyroid enlargement on ultrasound. Thirteen (92.9%) patients had hypothyroidism, and all patients had significantly elevated circulating thyroid antibodies. Compared with patients without thyroiditis, patients with IgG4-related thyroiditis had less submandibular gland involvement and lacrimal gland involvement and lower serum IgG4 and T-IgE levels (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.019,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.022,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004, and\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.006, respectively) and more single-organ involvement (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.011). After treatment, the symptoms were relieved, while the size of the thyroid gland did not change significantly, and levothyroxine as a supplemental therapy was still needed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>IgG4-related thyroiditis is a distinct subtype of IgG4-RD characterized by positive circulating thyroid antibodies and a high rate of hypothyroidism. Although compression symptoms could be relieved with treatment, the thyroid size did not change significantly, and the damage to thyroid function was often irreversible.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-021-01942-x","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T05:03:07Z","timestamp":1626843787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical features and treatment efficacy for IgG4-related thyroiditis"],"prefix":"10.1186","volume":"16","author":[{"given":"Xinxin","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boju","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6426-7586","authenticated-orcid":false,"given":"Xuejun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7808-9867","authenticated-orcid":false,"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"key":"1942_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","volume":"16","author":"CA Perugino","year":"2020","unstructured":"Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020;16:702\u201314.","journal-title":"Nat Rev Rheumatol"},{"key":"1942_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","volume":"78","author":"ZS Wallace","year":"2019","unstructured":"Wallace ZS, Zhang Y, Perugino CA, et al. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheumatic Diseases. 2019;78:406\u201312.","journal-title":"Ann Rheumatic Diseases"},{"key":"1942_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Modern Rheumatol. 2012;22:21\u201330.","journal-title":"Modern Rheumatol"},{"key":"1942_CR4","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/S2665-9913(19)30017-7","volume":"1","author":"W Zhang","year":"2019","unstructured":"Zhang W, Stone JH. Management of IgG4-related disease. Lancet Rheumatol. 2019;1:e55\u201365.","journal-title":"Lancet Rheumatol"},{"key":"1942_CR5","doi-asserted-by":"publisher","first-page":"iii123","DOI":"10.1093\/rheumatology\/kez667","volume":"59","author":"F Maritati","year":"2020","unstructured":"Maritati F, Peyronel F, Vaglio A. IgG4-related disease: a clinical perspective. Rheumatology (Oxford). 2020;59:iii123\u201331.","journal-title":"Rheumatology (Oxford)"},{"key":"1942_CR6","first-page":"m1067","volume":"369","author":"M Lanzillotta","year":"2020","unstructured":"Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ (Clin Res ed). 2020;369:m1067.","journal-title":"BMJ (Clin Res ed)."},{"key":"1942_CR7","doi-asserted-by":"publisher","first-page":"R175","DOI":"10.1530\/EJE-18-1024","volume":"180","author":"M Rotondi","year":"2019","unstructured":"Rotondi M, Carbone A, Coperchini F, Fonte R, Chiovato L. Diagnosis of endocrine disease: IgG4-related thyroid autoimmune disease. Eur J Endocrinol. 2019;180:R175\u201383.","journal-title":"Eur J Endocrinol"},{"key":"1942_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/apm.13067","volume":"128","author":"J Lintusaari","year":"2020","unstructured":"Lintusaari J, Vesaniemi E, Kalfert D, et al. IgG4-positive plasma cells in Hashimoto thyroiditis: IgG4-related disease or inflammation-related IgG4-positivity? APMIS: acta pathologica, microbiologica, et immunologica Scandinavica. 2020;128:531\u20138.","journal-title":"APMIS: acta pathologica, microbiologica, et immunologica Scandinavica"},{"key":"1942_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/thy.2019.0063","volume":"30","author":"Y Li","year":"2020","unstructured":"Li Y, Wang X, Liu Z, et al. Hashimoto\u2019s thyroiditis with increased IgG4-positive plasma cells: using thyroid-specific diagnostic criteria may identify early phase IgG4 thyroiditis. Thyroid. 2020;30:251\u201361.","journal-title":"Thyroid"},{"key":"1942_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1507\/endocrj.EJ20-0557","volume":"68","author":"K Takeshima","year":"2021","unstructured":"Takeshima K, Li Y, Kakudo K, et al. Proposal of diagnostic criteria for IgG4-related thyroid disease. Endocrine J. 2021;68:1\u20136.","journal-title":"Endocrine J"},{"key":"1942_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1507\/endocrj.EJ11-0309","volume":"59","author":"K Kakudo","year":"2012","unstructured":"Kakudo K, Li Y, Taniguchi E, et al. IgG4-related disease of the thyroid glands. Endocrine J. 2012;59:273\u201381.","journal-title":"Endocrine J"},{"key":"1942_CR12","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1440-1827.2009.02419.x","volume":"59","author":"Y Li","year":"2009","unstructured":"Li Y, Bai Y, Liu Z, et al. Immunohistochemistry of IgG4 can help subclassify Hashimoto\u2019s autoimmune thyroiditis. Pathol Int. 2009;59:636\u201341.","journal-title":"Pathol Int"},{"key":"1942_CR13","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/acr.20215","volume":"62","author":"M Dahlgren","year":"2010","unstructured":"Dahlgren M, Khosroshahi A, Nielsen GP, Deshpande V, Stone JH. Riedel\u2019s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res. 2010;62:1312\u20138.","journal-title":"Arthritis Care Res"},{"key":"1942_CR14","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1089\/thy.2011.0404","volume":"22","author":"M Pusztaszeri","year":"2012","unstructured":"Pusztaszeri M, Triponez F, Pache JC, Bongiovanni M. Riedel\u2019s thyroiditis with increased IgG4 plasma cells: evidence for an underlying IgG4-related sclerosing disease? Thyroid. 2012;22:964\u20138.","journal-title":"Thyroid"},{"key":"1942_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12022-015-9368-5","volume":"26","author":"PW Raess","year":"2015","unstructured":"Raess PW, Habashi A, El Rassi E, et al. Overlapping morphologic and immunohistochemical features of hashimoto thyroiditis and IgG4-related thyroid disease. Endocrine Pathol. 2015;26:170\u20137.","journal-title":"Endocrine Pathol"},{"key":"1942_CR16","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1210\/jc.2009-1794","volume":"95","author":"Y Li","year":"2010","unstructured":"Li Y, Nishihara E, Hirokawa M, et al. Distinct clinical, serological, and sonographic characteristics of hashimoto\u2019s thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab. 2010;95:1309\u201317.","journal-title":"J Clin Endocrinol Metab"},{"key":"1942_CR17","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.ultrasmedbio.2004.09.004","volume":"30","author":"E Ng","year":"2004","unstructured":"Ng E, Chen T, Lam R, Sin D, Ying M. Three-dimensional ultrasound measurement of thyroid volume in asymptomatic male Chinese. Ultrasound Med Biol. 2004;30:1427\u201333.","journal-title":"Ultrasound Med Biol"},{"key":"1942_CR18","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/acr.23543","volume":"70","author":"ZS Wallace","year":"2018","unstructured":"Wallace ZS, Khosroshahi A, Carruthers MD, et al. An international multispecialty validation study of the IgG4-related disease responder index. Arthritis Care Res. 2018;70:1671\u20138.","journal-title":"Arthritis Care Res"},{"key":"1942_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","volume":"45","author":"C Campochiaro","year":"2016","unstructured":"Campochiaro C, Ramirez GA, Bozzolo EP, et al. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scand J Rheumatol. 2016;45:135\u201345.","journal-title":"Scand J Rheumatol"},{"key":"1942_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/rheumatology\/key227","volume":"58","author":"F Yunyun","year":"2019","unstructured":"Yunyun F, Yu P, Panpan Z, et al. Efficacy and safety of low dose Mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial. Rheumatology (Oxford). 2019;58:52\u201360.","journal-title":"Rheumatology (Oxford)"},{"key":"1942_CR21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","volume":"13","author":"P Caturegli","year":"2014","unstructured":"Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13:391\u20137.","journal-title":"Autoimmun Rev"},{"key":"1942_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2155-9899.1000568","volume":"09","author":"K Inomata","year":"2018","unstructured":"Inomata K, Kurisaki H, Yamashita H, et al. Identification of thyroglobulin and its isoforms as target antigens for IgG4 thyroiditis. J Clin Cell Immunol. 2018;09:2.","journal-title":"J Clin Cell Immunol"},{"key":"1942_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000452623","volume":"5","author":"D Kottahachchi","year":"2016","unstructured":"Kottahachchi D, Topliss DJ. Immunoglobulin G4-related thyroid diseases. Eur Thyroid J. 2016;5:231\u20139.","journal-title":"Eur Thyroid J"},{"key":"1942_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13075-017-1432-8","volume":"19","author":"M Ozawa","year":"2017","unstructured":"Ozawa M, Fujinaga Y, Asano J, et al. Clinical features of IgG4-related periaortitis\/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case-control study. Arthritis Res Ther. 2017;19:223.","journal-title":"Arthritis Res Ther"},{"key":"1942_CR25","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/rheumatology\/key397","volume":"58","author":"L Wang","year":"2019","unstructured":"Wang L, Zhang P, Zhang X, et al. Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients. Rheumatology (Oxford). 2019;58:820\u201330.","journal-title":"Rheumatology (Oxford)"},{"key":"1942_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3904\/kjim.2014.283","volume":"31","author":"IS Lee","year":"2016","unstructured":"Lee IS, Lee JU, Lee KJ, et al. Painful immunoglobulin G4-related thyroiditis treated by total thyroidectomy. Korean J Intern Med. 2016;31:399\u2013402.","journal-title":"Korean J Intern Med"},{"key":"1942_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13000-017-0681-9","volume":"13","author":"Y Sakai","year":"2018","unstructured":"Sakai Y, Imamura Y. Case report: IgG4-related mass-forming thyroiditis accompanied by regional lymphadenopathy. Diagn Pathol. 2018;13:3.","journal-title":"Diagn Pathol"},{"key":"1942_CR28","doi-asserted-by":"publisher","first-page":"520","DOI":"10.5603\/EP.2016.0061","volume":"67","author":"D Dutta","year":"2016","unstructured":"Dutta D, Ahuja A, Selvan C. Immunoglobulin G4 related thyroid disorders: diagnostic challenges and clinical outcomes. Endokrynol Pol. 2016;67:520\u20134.","journal-title":"Endokrynol Pol"},{"key":"1942_CR29","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1210\/jc.2011-0617","volume":"96","author":"JV Hennessey","year":"2011","unstructured":"Hennessey JV. Clinical review: Riedel\u2019s thyroiditis: a clinical review. J Clin Endocrinol Metab. 2011;96:3031\u201341.","journal-title":"J Clin Endocrinol Metab"},{"key":"1942_CR30","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/1756-185X.13633","volume":"22","author":"P Zhang","year":"2019","unstructured":"Zhang P, Gong Y, Liu Z, et al. Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: a prospective clinical trial. Int J Rheumatic Diseases. 2019;22:1479\u201388.","journal-title":"Int J Rheumatic Diseases"},{"key":"1942_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10067-019-04880-z","volume":"39","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhang Y, Bian W, et al. Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease. Clin Rheumatol. 2020;39:491\u20137.","journal-title":"Clin Rheumatol"},{"key":"1942_CR32","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1210\/jc.2012-4050","volume":"98","author":"SB Soh","year":"2013","unstructured":"Soh SB, Pham A, O\u2019Hehir RE, Cherk M, Topliss DJ. Novel use of rituximab in a case of Riedel\u2019s thyroiditis refractory to glucocorticoids and tamoxifen. J Clin Endocrinol Metab. 2013;98:3543\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1942_CR33","doi-asserted-by":"publisher","first-page":"453","DOI":"10.7326\/M18-0284","volume":"170","author":"I Guldvog","year":"2019","unstructured":"Guldvog I, Reitsma LC, Johnsen L, et al. Thyroidectomy versus medical management for euthyroid patients with hashimoto disease and persisting symptoms: a randomized trial. Ann Internal Med. 2019;170:453\u201364.","journal-title":"Ann Internal Med"},{"key":"1942_CR34","first-page":"1086","volume":"25","author":"Y Li","year":"2012","unstructured":"Li Y, Zhou G, Ozaki T, et al. Distinct histopathological features of Hashimoto\u2019s thyroiditis with respect to IgG4-related disease. Modern Pathol Off J US Can Acad Pathol. 2012;25:1086\u201397.","journal-title":"Modern Pathol Off J US Can Acad Pathol"},{"key":"1942_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/jcu.1870140208","volume":"14","author":"N Hayashi","year":"1986","unstructured":"Hayashi N, Tamaki N, Konishi J, et al. Sonography of Hashimoto\u2019s thyroiditis. J Clin Ultrasound JCU. 1986;14:123\u20136.","journal-title":"J Clin Ultrasound JCU"}],"updated-by":[{"DOI":"10.1186\/s13023-021-02071-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000}}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01942-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01942-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01942-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T03:06:52Z","timestamp":1635822412000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01942-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1942"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01942-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"assertion":[{"value":"13 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13023-021-02071-1","URL":"https:\/\/doi.org\/10.1186\/s13023-021-02071-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in compliance with the Declaration of Helsinki and was approved by the Ethics Committee of Peking Union Medical College Hospital (No. S-442). Formal informed consent was obtained from all patients included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"324"}}